Induction of IgG2 and IgG4 B‐cell memory following sublingual immunotherapy for ryegrass pollen allergy
Background While treatment for atopic rhinitis is aimed mostly to relieve symptoms, only allergen‐specific immunotherapy (AIT) is targeted to modify the natural history of allergic diseases. This results in sustained clinical tolerance, even when treatment has stopped. The immunomodulatory effects o...
Saved in:
Published in | Allergy (Copenhagen) Vol. 75; no. 5; pp. 1121 - 1132 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Zurich
Blackwell Publishing Ltd
01.05.2020
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0105-4538 1398-9995 1398-9995 |
DOI | 10.1111/all.14073 |
Cover
Abstract | Background
While treatment for atopic rhinitis is aimed mostly to relieve symptoms, only allergen‐specific immunotherapy (AIT) is targeted to modify the natural history of allergic diseases. This results in sustained clinical tolerance, even when treatment has stopped. The immunomodulatory effects of AIT are attributed mainly to increased regulatory T‐cell function and increased allergen‐specific IgG4, yet little is known about the effect on the memory B‐cell compartment.
Objective
We aimed to examine the effects of AIT on the IgE‐ and IgG subclass‐expressing memory B cells.
Methods
We recruited 29 patients with atopic seasonal rhinoconjunctivitis and performed a longitudinal analysis of the peripheral immune compartment before, during, and after sublingual immunotherapy (SLIT) for allergy to temperate grass pollen, predominantly to ryegrass pollen (RGP; Lolium perenne). Using flow cytometry on peripheral blood mononuclear cells and serum immunoassays, we analyzed the effects of a 4 months preseasonal treatment regimen comprising two or three courses in consecutive years on circulating IgE+ and IgG+ memory B cells and allergen‐specific Ig levels.
Results
SLIT increased RGP‐specific serum IgG2 and IgG4, as well as the frequencies of IgG2+ and IgG4+ memory B cells, whereas no effect was observed on the IgE+ memory B‐cell compartment. Furthermore, SLIT enhanced proportions of regulatory T cells specific to RGP. These changes were associated with clinical improvement.
Conclusion
Our data provide evidence for immunological effects of SLIT on B‐cell memory. Skewing responses toward IgG2 and IgG4 subclasses might be a mechanism to suppress IgE‐mediated allergic responses.
This study examines the effect of ryegrass pollen AIT on B‐cell responses in a population of 29 patients with allergic rhinitis. Successful immunotherapy for ryegrass pollen allergy increases allergen‐specific IgG2 and IgG4 serum levels, and proportions of IgG2‐ and IgG4‐expressing memory B cells. Skewing toward the anti‐inflammatory IgG2 and IgG4 subclasses might be a mechanism to suppress IgE‐mediated allergic responses. |
---|---|
AbstractList | While treatment for atopic rhinitis is aimed mostly to relieve symptoms, only allergen-specific immunotherapy (AIT) is targeted to modify the natural history of allergic diseases. This results in sustained clinical tolerance, even when treatment has stopped. The immunomodulatory effects of AIT are attributed mainly to increased regulatory T-cell function and increased allergen-specific IgG4 , yet little is known about the effect on the memory B-cell compartment.BACKGROUNDWhile treatment for atopic rhinitis is aimed mostly to relieve symptoms, only allergen-specific immunotherapy (AIT) is targeted to modify the natural history of allergic diseases. This results in sustained clinical tolerance, even when treatment has stopped. The immunomodulatory effects of AIT are attributed mainly to increased regulatory T-cell function and increased allergen-specific IgG4 , yet little is known about the effect on the memory B-cell compartment.We aimed to examine the effects of AIT on the IgE- and IgG subclass-expressing memory B cells.OBJECTIVEWe aimed to examine the effects of AIT on the IgE- and IgG subclass-expressing memory B cells.We recruited 29 patients with atopic seasonal rhinoconjunctivitis and performed a longitudinal analysis of the peripheral immune compartment before, during, and after sublingual immunotherapy (SLIT) for allergy to temperate grass pollen, predominantly to ryegrass pollen (RGP; Lolium perenne). Using flow cytometry on peripheral blood mononuclear cells and serum immunoassays, we analyzed the effects of a 4 months preseasonal treatment regimen comprising two or three courses in consecutive years on circulating IgE+ and IgG+ memory B cells and allergen-specific Ig levels.METHODSWe recruited 29 patients with atopic seasonal rhinoconjunctivitis and performed a longitudinal analysis of the peripheral immune compartment before, during, and after sublingual immunotherapy (SLIT) for allergy to temperate grass pollen, predominantly to ryegrass pollen (RGP; Lolium perenne). Using flow cytometry on peripheral blood mononuclear cells and serum immunoassays, we analyzed the effects of a 4 months preseasonal treatment regimen comprising two or three courses in consecutive years on circulating IgE+ and IgG+ memory B cells and allergen-specific Ig levels.SLIT increased RGP-specific serum IgG2 and IgG4 , as well as the frequencies of IgG2+ and IgG4+ memory B cells, whereas no effect was observed on the IgE+ memory B-cell compartment. Furthermore, SLIT enhanced proportions of regulatory T cells specific to RGP. These changes were associated with clinical improvement.RESULTSSLIT increased RGP-specific serum IgG2 and IgG4 , as well as the frequencies of IgG2+ and IgG4+ memory B cells, whereas no effect was observed on the IgE+ memory B-cell compartment. Furthermore, SLIT enhanced proportions of regulatory T cells specific to RGP. These changes were associated with clinical improvement.Our data provide evidence for immunological effects of SLIT on B-cell memory. Skewing responses toward IgG2 and IgG4 subclasses might be a mechanism to suppress IgE-mediated allergic responses.CONCLUSIONOur data provide evidence for immunological effects of SLIT on B-cell memory. Skewing responses toward IgG2 and IgG4 subclasses might be a mechanism to suppress IgE-mediated allergic responses. Background While treatment for atopic rhinitis is aimed mostly to relieve symptoms, only allergen‐specific immunotherapy (AIT) is targeted to modify the natural history of allergic diseases. This results in sustained clinical tolerance, even when treatment has stopped. The immunomodulatory effects of AIT are attributed mainly to increased regulatory T‐cell function and increased allergen‐specific IgG4, yet little is known about the effect on the memory B‐cell compartment. Objective We aimed to examine the effects of AIT on the IgE‐ and IgG subclass‐expressing memory B cells. Methods We recruited 29 patients with atopic seasonal rhinoconjunctivitis and performed a longitudinal analysis of the peripheral immune compartment before, during, and after sublingual immunotherapy (SLIT) for allergy to temperate grass pollen, predominantly to ryegrass pollen (RGP; Lolium perenne). Using flow cytometry on peripheral blood mononuclear cells and serum immunoassays, we analyzed the effects of a 4 months preseasonal treatment regimen comprising two or three courses in consecutive years on circulating IgE+ and IgG+ memory B cells and allergen‐specific Ig levels. Results SLIT increased RGP‐specific serum IgG2 and IgG4, as well as the frequencies of IgG2+ and IgG4+ memory B cells, whereas no effect was observed on the IgE+ memory B‐cell compartment. Furthermore, SLIT enhanced proportions of regulatory T cells specific to RGP. These changes were associated with clinical improvement. Conclusion Our data provide evidence for immunological effects of SLIT on B‐cell memory. Skewing responses toward IgG2 and IgG4 subclasses might be a mechanism to suppress IgE‐mediated allergic responses. This study examines the effect of ryegrass pollen AIT on B‐cell responses in a population of 29 patients with allergic rhinitis. Successful immunotherapy for ryegrass pollen allergy increases allergen‐specific IgG2 and IgG4 serum levels, and proportions of IgG2‐ and IgG4‐expressing memory B cells. Skewing toward the anti‐inflammatory IgG2 and IgG4 subclasses might be a mechanism to suppress IgE‐mediated allergic responses. This study examines the effect of ryegrass pollen AIT on B‐cell responses in a population of 29 patients with allergic rhinitis. Successful immunotherapy for ryegrass pollen allergy increases allergen‐specific IgG 2 and IgG 4 serum levels, and proportions of IgG 2‐ and IgG 4 ‐expressing memory B cells. Skewing toward the anti‐inflammatory IgG 2 and IgG 4 subclasses might be a mechanism to suppress IgE‐mediated allergic responses. BackgroundWhile treatment for atopic rhinitis is aimed mostly to relieve symptoms, only allergen‐specific immunotherapy (AIT) is targeted to modify the natural history of allergic diseases. This results in sustained clinical tolerance, even when treatment has stopped. The immunomodulatory effects of AIT are attributed mainly to increased regulatory T‐cell function and increased allergen‐specific IgG4, yet little is known about the effect on the memory B‐cell compartment.ObjectiveWe aimed to examine the effects of AIT on the IgE‐ and IgG subclass‐expressing memory B cells.MethodsWe recruited 29 patients with atopic seasonal rhinoconjunctivitis and performed a longitudinal analysis of the peripheral immune compartment before, during, and after sublingual immunotherapy (SLIT) for allergy to temperate grass pollen, predominantly to ryegrass pollen (RGP; Lolium perenne). Using flow cytometry on peripheral blood mononuclear cells and serum immunoassays, we analyzed the effects of a 4 months preseasonal treatment regimen comprising two or three courses in consecutive years on circulating IgE+ and IgG+ memory B cells and allergen‐specific Ig levels.ResultsSLIT increased RGP‐specific serum IgG2 and IgG4, as well as the frequencies of IgG2+ and IgG4+ memory B cells, whereas no effect was observed on the IgE+ memory B‐cell compartment. Furthermore, SLIT enhanced proportions of regulatory T cells specific to RGP. These changes were associated with clinical improvement.ConclusionOur data provide evidence for immunological effects of SLIT on B‐cell memory. Skewing responses toward IgG2 and IgG4 subclasses might be a mechanism to suppress IgE‐mediated allergic responses. |
Author | McKenzie, Craig I. Varese, Nirupama Hew, Mark Aui, Pei M. Bakx, Amy T. C. M. Zelm, Menno C. Heeringa, Jorn J. Rolland, Jennifer M. O’Hehir, Robyn E. |
AuthorAffiliation | 5 School of Public Health and Preventive Medicine Monash University Melbourne Vic. Australia 4 Department of Respiratory Medicine Allergy and Clinical Immunology (Research) Central Clinical School Monash University, and Alfred Hospital Melbourne Vic. Australia 1 Department of Immunology and Pathology Central Clinical School Monash University Melbourne Vic. Australia 2 Department of Immunology Erasmus MC University Medical Center Rotterdam the Netherlands 3 Department of Pediatrics Erasmus MC University Medical Center Rotterdam the Netherlands |
AuthorAffiliation_xml | – name: 5 School of Public Health and Preventive Medicine Monash University Melbourne Vic. Australia – name: 4 Department of Respiratory Medicine Allergy and Clinical Immunology (Research) Central Clinical School Monash University, and Alfred Hospital Melbourne Vic. Australia – name: 1 Department of Immunology and Pathology Central Clinical School Monash University Melbourne Vic. Australia – name: 2 Department of Immunology Erasmus MC University Medical Center Rotterdam the Netherlands – name: 3 Department of Pediatrics Erasmus MC University Medical Center Rotterdam the Netherlands |
Author_xml | – sequence: 1 givenname: Jorn J. orcidid: 0000-0003-0304-8977 surname: Heeringa fullname: Heeringa, Jorn J. organization: University Medical Center – sequence: 2 givenname: Craig I. orcidid: 0000-0001-7070-620X surname: McKenzie fullname: McKenzie, Craig I. organization: Monash University – sequence: 3 givenname: Nirupama orcidid: 0000-0001-9074-3710 surname: Varese fullname: Varese, Nirupama organization: Monash University, and Alfred Hospital – sequence: 4 givenname: Mark orcidid: 0000-0002-7498-0000 surname: Hew fullname: Hew, Mark organization: Monash University – sequence: 5 givenname: Amy T. C. M. surname: Bakx fullname: Bakx, Amy T. C. M. organization: Monash University – sequence: 6 givenname: Pei M. orcidid: 0000-0002-2314-9989 surname: Aui fullname: Aui, Pei M. organization: Monash University – sequence: 7 givenname: Jennifer M. orcidid: 0000-0002-7891-983X surname: Rolland fullname: Rolland, Jennifer M. organization: Monash University, and Alfred Hospital – sequence: 8 givenname: Robyn E. orcidid: 0000-0002-3489-7595 surname: O’Hehir fullname: O’Hehir, Robyn E. organization: Monash University, and Alfred Hospital – sequence: 9 givenname: Menno C. orcidid: 0000-0003-4161-1919 surname: Zelm fullname: Zelm, Menno C. email: menno.vanzelm@monash.edu organization: Monash University, and Alfred Hospital |
BookMark | eNpdkcFqHDEMhk1JaDZpD30DQy-9TGKP7bV9KaShSRYWcknPxuPRTrx47K290zC3PEKfsU9SbxIKjQ6SQB8_v6RTdBRTBIQ-UXJOa1zYEM4pJ5K9QwvKtGq01uIILQglouGCqRN0WsqWECJbTd6jE0aFkozIBfKr2E9u71PEaYNXw02LbewPDcff_jz9dhACHmFMecabFEJ69HHAZepCrZMN2I_jFNP-AbLdHZCM8wxDtqXgXeUh4uoO8jB_QMcbGwp8fK1n6Mf19_ur22Z9d7O6ulw3W05b1nT9ctl1vWSqY9q1nC-tcpz1jhHVq7bmpRAb3iprwRJwAhxxUvKeAFXMduwMfX3R3U3dCL2DuM82mF32o82zSdab_yfRP5gh_TKSUakZrwJfXgVy-jlB2ZvRl8MdbIQ0FVM9UKWUbEVFP79Bt2nKsa5nWk6YJooLXamLF-rRB5j_OaHEHL5n6n3M8_fM5Xr93LC_KYGRag |
ContentType | Journal Article |
Copyright | 2019 The Authors. published by John Wiley & Sons Ltd. 2019. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2019 The Authors. Allergy published by John Wiley & Sons Ltd. |
Copyright_xml | – notice: 2019 The Authors. published by John Wiley & Sons Ltd. – notice: 2019. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2019 The Authors. Allergy published by John Wiley & Sons Ltd. |
DBID | 24P 7T5 H94 K9. 7X8 5PM |
DOI | 10.1111/all.14073 |
DatabaseName | Wiley Online Library Open Access Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library website url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | HEERINGA et al |
EISSN | 1398-9995 |
EndPage | 1132 |
ExternalDocumentID | PMC7317934 ALL14073 |
Genre | article |
GrantInformation_xml | – fundername: National Health and Medical Research Council funderid: GNT1117687 – fundername: Sophia Children’s Hospital Fund funderid: S698 – fundername: Num Pon Soon Charitable Trust – fundername: Sophia Children’s Hospital Fund grantid: S698 – fundername: ; grantid: GNT1117687 |
GroupedDBID | .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT 7T5 AAMMB AEFGJ AEYWJ AGHNM AGXDD AGYGG AIDQK AIDYY H94 K9. 7X8 5PM |
ID | FETCH-LOGICAL-j4123-bd66bbd738b39c2446a8c43dc308d82308655f428aaea0ec5ec0c774d0e183ab3 |
IEDL.DBID | DR2 |
ISSN | 0105-4538 1398-9995 |
IngestDate | Thu Aug 21 13:46:16 EDT 2025 Fri Jul 11 10:30:59 EDT 2025 Sun Jul 13 04:48:48 EDT 2025 Wed Jan 22 16:34:02 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | Attribution-NonCommercial This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-j4123-bd66bbd738b39c2446a8c43dc308d82308655f428aaea0ec5ec0c774d0e183ab3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Jorn J. Heeringa and Craig I. McKenzie equal contribution. |
ORCID | 0000-0002-2314-9989 0000-0001-7070-620X 0000-0002-7498-0000 0000-0003-0304-8977 0000-0001-9074-3710 0000-0003-4161-1919 0000-0002-7891-983X 0000-0002-3489-7595 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.14073 |
PMID | 31587307 |
PQID | 2403908459 |
PQPubID | 34098 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7317934 proquest_miscellaneous_2301888725 proquest_journals_2403908459 wiley_primary_10_1111_all_14073_ALL14073 |
PublicationCentury | 2000 |
PublicationDate | May 2020 |
PublicationDateYYYYMMDD | 2020-05-01 |
PublicationDate_xml | – month: 05 year: 2020 text: May 2020 |
PublicationDecade | 2020 |
PublicationPlace | Zurich |
PublicationPlace_xml | – name: Zurich – name: Hoboken |
PublicationTitle | Allergy (Copenhagen) |
PublicationYear | 2020 |
Publisher | Blackwell Publishing Ltd John Wiley and Sons Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: John Wiley and Sons Inc |
References | 1998; 160 1989; 44 2011; 118 2005; 136 2006; 36 2004; 4 2010; 184 2005; 60 2014; 133 2003; 112 2012; 129 2003; 111 2014; 134 2004; 133 2017; 72 2012; 130 2018; 9 2015; 135 2015; 175 2004; 34 2003; 3 2018; 73 2002; 109 1998; 53 2018; 141 2014; 92 2010; 2010 2013; 44 2019; 74 2009; 180 1983; 130 2013; 309 2010; 125 1994; 152 2008; 19 2010; 126 2005; 116 2002; 32 2007; 120 2008; 329 1999; 341 2006; 6 1997; 27 2013; 341 2015; 8 2015; 7 2010; 40 1996; 97 2017; 95 2018; 198 2010; 47 2004; 113 2017; 17 2019 2009; 101 2016; 137 2016; 27 2001; 31 1980; 125 |
References_xml | – volume: 341 start-page: 1205 issue: 6151 year: 2013 end-page: 1211 article-title: Diversity among memory B cells: origin, consequences, and utility publication-title: Science – volume: 27 start-page: 276 issue: 3 year: 2016 end-page: 282 article-title: Differential response in allergen‐specific IgE, IgGs, and IgA levels for predicting outcome of oral immunotherapy publication-title: Pediatr Allergy Immunol – volume: 152 start-page: 4368 issue: 9 year: 1994 end-page: 4374 article-title: B7/CD28‐dependent IL‐5 production by human resting T cells is inhibited by IL‐10 publication-title: J Immunol – volume: 129 start-page: 717 issue: 3 year: 2012 end-page: 725 article-title: SQ‐standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial publication-title: J Allergy Clin Immunol – volume: 309 start-page: 1278 issue: 12 year: 2013 end-page: 1288 article-title: Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review publication-title: JAMA – volume: 198 start-page: 126 issue: 1 year: 2018 end-page: 128 article-title: Epidemic thunderstorm asthma protection with five‐grass pollen tablet sublingual immunotherapy: a clinical trial publication-title: Am J Respir Crit Care Med – volume: 6 start-page: 761 issue: 10 year: 2006 end-page: 771 article-title: Immunological mechanisms of allergen‐specific immunotherapy publication-title: Nat Rev Immunol – volume: 160 start-page: 3555 issue: 7 year: 1998 end-page: 3561 article-title: IgE versus IgG4 production can be differentially regulated by IL‐10 publication-title: J Immunol – volume: 113 start-page: 1025 issue: 6 year: 2004 end-page: 1034 article-title: Mechanisms of immunotherapy publication-title: J Allergy Clin Immunol – volume: 135 start-page: 1249 issue: 5 year: 2015 end-page: 1256 article-title: IgG4 inhibits peanut‐induced basophil and mast cell activation in peanut‐tolerant children sensitized to peanut major allergens publication-title: J Allergy Clin Immunol – volume: 44 start-page: 412 issue: 6 year: 1989 end-page: 418 article-title: Predictive value of venom‐specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom publication-title: Allergy – volume: 130 start-page: 1097 issue: 5 year: 2012 end-page: 1107 article-title: Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta‐analysis‐based comparison publication-title: J Allergy Clin Immunol – volume: 136 start-page: 287 issue: 3 year: 2005 end-page: 294 article-title: Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites publication-title: Int Arch Allergy Immunol – volume: 31 start-page: 1392 issue: 9 year: 2001 end-page: 1397 article-title: Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six‐year follow‐up study publication-title: Clin Exp Allergy – volume: 111 start-page: 1255 issue: 6 year: 2003 end-page: 1261 article-title: Induction of IL‐10+CD4+CD25+ T cells by grass pollen immunotherapy publication-title: J Allergy Clin Immunol – volume: 133 start-page: 130 issue: 1 year: 2014 end-page: 138 article-title: Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T‐cell generation publication-title: J Allergy Clin Immunol – volume: 9 start-page: 958 year: 2018 end-page: 958 article-title: Potential of murine IgG1 and human IgG4 to inhibit the classical complement and Fcγ receptor activation pathways publication-title: Front Immunol – volume: 95 start-page: 744 issue: 9 year: 2017 end-page: 752 article-title: Human IgG2‐ and IgG4‐expressing memory B cells display enhanced molecular and phenotypic signs of maturity and accumulate with age publication-title: Immunol Cell Biol – volume: 125 start-page: S73 issue: 2 Suppl 2 year: 2010 end-page: S80 article-title: IgE, mast cells, basophils, and eosinophils publication-title: J Allergy Clin Immunol – volume: 60 start-page: 251 issue: 2 year: 2005 end-page: 255 article-title: Bahia grass pollen specific IgE is common in seasonal rhinitis patients but has limited cross‐reactivity with Ryegrass publication-title: Allergy – volume: 130 start-page: 722 issue: 2 year: 1983 end-page: 726 article-title: Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4‐restricted response publication-title: J Immunol – volume: 133 start-page: 1 issue: 1 year: 2004 end-page: 13 article-title: High dose allergen stimulation of T cells from house dust mite‐allergic subjects induces expansion of IFN‐gamma+ T Cells, apoptosis of CD4+IL‐4+ T cells and T cell anergy publication-title: Int Arch Allergy Immunol – year: 2019 article-title: Recent developments and highlights in immune monitoring of allergen immunotherapy publication-title: Allergy – volume: 36 start-page: 32 issue: 1 year: 2006 end-page: 39 article-title: Absence of systemic immunologic changes during dose build‐up phase and early maintenance period in effective specific sublingual immunotherapy in children publication-title: Clin Exp Allergy – volume: 113 start-page: 395 issue: 3 year: 2004 end-page: 400 article-title: Immunologic influences on allergy and the TH1/TH2 balance publication-title: J Allergy Clin Immunol – volume: 92 start-page: 729 issue: 8 year: 2014 end-page: 733 article-title: Human immunoglobulin classes and subclasses show variability in VDJ gene mutation levels publication-title: Immunol Cell Biol – volume: 8 start-page: 17 issue: 1 year: 2015 article-title: Mechanisms of allergen‐specific immunotherapy and immune tolerance to allergens publication-title: World Allergy Organ J – volume: 53 start-page: 662 issue: 7 year: 1998 end-page: 672 article-title: Double‐blind, placebo‐controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization publication-title: Allergy – volume: 44 start-page: 407 issue: 3 year: 2013 end-page: 416 article-title: Clinical relevance is associated with allergen‐specific wheal size in skin prick testing publication-title: Clin Exp Allergy – volume: 74 start-page: 349 issue: 2 year: 2019 end-page: 360 article-title: Persistent regulatory T‐cell response 2 years after 3 years of grass tablet SLIT: Links to reduced eosinophil counts, sIgE levels, and clinical benefit publication-title: Allergy – volume: 112 start-page: 915 issue: 5 year: 2003 end-page: 922 article-title: Inhibition of allergen‐IgE binding to B cells by IgG antibodies after grass pollen immunotherapy publication-title: J Allergy Clin Immunol – volume: 341 start-page: 468 issue: 7 year: 1999 end-page: 475 article-title: Long‐term clinical efficacy of grass‐pollen immunotherapy publication-title: N Engl J Med – volume: 109 start-page: 251 issue: 2 year: 2002 end-page: 256 article-title: Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT‐study) publication-title: J Allergy Clin Immunol – volume: 184 start-page: 2194 issue: 4 year: 2010 end-page: 2203 article-title: Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation publication-title: J Immunol – volume: 180 start-page: 936 issue: 10 year: 2009 end-page: 947 article-title: House dust mite sublingual immunotherapy: the role for transforming growth factor‐beta and functional regulatory T cells publication-title: Am J Respir Crit Care Med – volume: 175 start-page: 1301 issue: 8 year: 2015 end-page: 1309 article-title: Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis: a systematic review and meta‐analysis publication-title: JAMA Intern Med – volume: 137 start-page: 1256 issue: 4 year: 2016 end-page: 1258 article-title: Parameters determining the efficacy of CD32 to inhibit activation of FcERI in human basophils publication-title: J Allergy Clin Immunol – volume: 329 start-page: 112 issue: 1–2 year: 2008 end-page: 124 article-title: Efficient generation of monoclonal antibodies from single human B cells by single cell RT‐PCR and expression vector cloning publication-title: J Immunol Methods – volume: 60 start-page: 4 issue: 1 year: 2005 end-page: 12 article-title: Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis publication-title: Allergy – volume: 7 start-page: 280ps6 issue: 280 year: 2015 end-page: 280ps6 article-title: Advances in allergen immunotherapy: aiming for complete tolerance to allergens publication-title: Sci Transl Med – volume: 116 start-page: 608 issue: 3 year: 2005 end-page: 613 article-title: Allergen‐specific immunotherapy with recombinant grass pollen allergens publication-title: J Allergy Clin Immunol – volume: 97 start-page: 1761 issue: 7 year: 1996 end-page: 1766 article-title: CD40 expression by human peripheral blood eosinophils publication-title: J Clin Invest – volume: 118 start-page: 2150 issue: 8 year: 2011 end-page: 2158 article-title: Human memory B cells originate from three distinct germinal center‐dependent and ‐independent maturation pathways publication-title: Blood – volume: 101 start-page: 191 year: 2009 end-page: 236 article-title: Interleukin 5 in the link between the innate and acquired immune response publication-title: Adv Immunol – volume: 19 start-page: 110 issue: 2 year: 2008 end-page: 124 article-title: Worldwide time trends for symptoms of rhinitis and conjunctivitis: phase III of the international study of asthma and allergies in childhood publication-title: Pediatr Allergy Immunol – volume: 4 start-page: 313 issue: 4 year: 2004 end-page: 318 article-title: Mechanisms of immunotherapy: IgG revisited publication-title: Curr Opin Allergy Clin Immunol – volume: 31 start-page: 694 issue: 5 year: 2001 end-page: 704 article-title: Inhibition of IgE‐induced activation of human mast cells by IL‐10 publication-title: Clin Exp Allergy – volume: 125 start-page: 2735 issue: 6 year: 1980 end-page: 2741 article-title: Characterization of the Fc receptor for IgG on a human macrophage cell line, U937 publication-title: J Immunol – volume: 125 start-page: 131 issue: 1 year: 2010 end-page: 138 article-title: Long‐term clinical efficacy in grass pollen‐induced rhinoconjunctivitis after treatment with SQ‐standardized grass allergy immunotherapy tablet publication-title: J Allergy Clin Immunol – volume: 40 start-page: 598 issue: 4 year: 2010 end-page: 606 article-title: Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3‐expressing cells and elevated allergen‐specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E‐facilitated allergen binding to B cells publication-title: Clin Exp Allergy – volume: 126 start-page: 558 issue: 3 year: 2010 end-page: 566 article-title: Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta‐analysis publication-title: J Allergy Clin Immunol – volume: 17 start-page: 447 issue: 6 year: 2017 end-page: 452 article-title: The role of regulatory B cells in allergen immunotherapy publication-title: Curr Opin Allergy Clin Immunol – volume: 72 start-page: 759 issue: Suppl S103 year: 2017 article-title: Preseasonal grass pollen SLIT in at risk individuals confers protection from epidemic thunderstorm asthma publication-title: Allergy – volume: 3 start-page: 721 issue: 9 year: 2003 end-page: 732 article-title: The regulation of immunoglobulin E class‐switch recombination publication-title: Nat Rev Immunol – volume: 120 start-page: 707 issue: 3 year: 2007 end-page: 713 article-title: Sublingual immunotherapy induces IL‐10‐producing T regulatory cells, allergen‐specific T‐cell tolerance, and immune deviation publication-title: J Allergy Clin Immunol – volume: 73 start-page: 421 issue: 2 year: 2018 end-page: 430 article-title: Evolution of the IgE and IgG repertoire to a comprehensive array of allergen molecules in the first decade of life publication-title: Allergy – volume: 74 start-page: 1317 issue: 7 year: 2019 end-page: 1326 article-title: Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France publication-title: Allergy – volume: 92 start-page: 645 issue: 8 year: 2014 end-page: 646 article-title: B cells take their time: sequential IgG class switching over the course of an immune response? publication-title: Immunol Cell Biol – volume: 134 start-page: 688 issue: 3 year: 2014 end-page: 697 article-title: Human IgE+ B cells are derived from T cell‐dependent and T cell‐independent pathways publication-title: J Allergy Clin Immunol – volume: 34 start-page: 1209 issue: 8 year: 2004 end-page: 1219 article-title: Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin‐10+ T cells expressing peripheral tissue trafficking markers publication-title: Clin Exp Allergy – volume: 141 start-page: 1831 issue: 5 year: 2018 end-page: 1843 article-title: Expansion of blood IgG4(+) B, TH2, and regulatory T cells in patients with IgG4‐related disease publication-title: J Allergy Clin Immunol – volume: 27 start-page: 1007 issue: 9 year: 1997 end-page: 1015 article-title: Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T‐cell clones specific for Phl p 1, a major grass pollen allergen publication-title: Clin Exp Allergy – volume: 136 start-page: 134 issue: 2 year: 2005 end-page: 141 article-title: Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen publication-title: Int Arch Allergy Immunol – volume: 47 start-page: 1142 issue: 10 year: 2010 end-page: 1147 article-title: Exhaled nitric oxide in children with allergic rhinitis and/or asthma: a relationship with bronchial hyperreactivity publication-title: J Asthma – volume: 2010 start-page: 1 year: 2010 end-page: 7 article-title: FeNO as a marker of airways inflammation: the possible implications in childhood asthma management publication-title: J Allergy – volume: 32 start-page: 507 issue: 4 year: 2002 end-page: 514 article-title: Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial publication-title: Clin Exp Allergy – volume: 74 start-page: 483 issue: 3 year: 2019 end-page: 494 article-title: IgG4 drives M2a macrophages to a regulatory M2b‐like phenotype: potential implication in immune tolerance publication-title: Allergy |
SSID | ssj0007290 |
Score | 2.552364 |
Snippet | Background
While treatment for atopic rhinitis is aimed mostly to relieve symptoms, only allergen‐specific immunotherapy (AIT) is targeted to modify the... BackgroundWhile treatment for atopic rhinitis is aimed mostly to relieve symptoms, only allergen‐specific immunotherapy (AIT) is targeted to modify the natural... While treatment for atopic rhinitis is aimed mostly to relieve symptoms, only allergen-specific immunotherapy (AIT) is targeted to modify the natural history... This study examines the effect of ryegrass pollen AIT on B‐cell responses in a population of 29 patients with allergic rhinitis. Successful immunotherapy for... |
SourceID | pubmedcentral proquest wiley |
SourceType | Open Access Repository Aggregation Database Publisher |
StartPage | 1121 |
SubjectTerms | Allergens Allergic diseases Allergies Atopy B cells Flow cytometry IgE Immunoglobulin E Immunoglobulin G Immunological memory Immunological tolerance Immunomodulation Immunomodulators Immunoregulation Immunotherapy immunotherapy and tolerance induction Leukocytes (mononuclear) Lymphocytes B Lymphocytes T Memory cells Oral administration Original ORIGINAL ARTICLES Peripheral blood mononuclear cells Pollen Rhinitis Rhinoconjunctivitis |
Title | Induction of IgG2 and IgG4 B‐cell memory following sublingual immunotherapy for ryegrass pollen allergy |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.14073 https://www.proquest.com/docview/2403908459 https://www.proquest.com/docview/2301888725 https://pubmed.ncbi.nlm.nih.gov/PMC7317934 |
Volume | 75 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB0VDogLO6IslZE4cAnK4sSJOLGVRYAQohIHpMh2klIoKeoiVE58At_IlzDjpoX2hLhZsi3F8cz4zXjmGWDHEdJJKHvGljyzOMqQFbo8sBzh0L1NqFxNjuLVdXBW4xf3_n0J9oe1MAN-iFHAjTTD2GtScKk6v5RcNpuo5iihaH8dLyDe_OPbH-ooUcRXED9YHLW6YBWiLJ7RzDFUOZkT-RurmsOmOg8Pw88c5Jg87_W6ak-_TzA4_nMdCzBXgFB2MJCaRSil-RLMXBXX7MvQoAc9TMEDa2XsvH7qMpkn1ODs8Ovjk6L97IVydPssQ0FqveEByDoU0aLoZ5M1qOqkqO2iIW2G0L7eRqDOXilSkTN6wqVd769ArXpyd3RmFW8yWE8cDzlLJUGgVCK8UHmRRmwQyFBzL9GeHSZ0aUeFrhn6NFKm0k61n2pbI8RM7BSNh1TeKkznrTxdA-YoNwy18Mil5EEmIpVFrvRROrjmTmaXYXO4O3GhWJ2Y6AMjO-R-VIbtUTeqBK1c5mmrh2PQaKFjL1y_DGJsV-PXAYVHTKTa4z1549GQawuPTBYvw67ZtNGMobOEvyc22xUfXF6axvrfh27ArEv-ukmY3ITpbruXbiGo6aoKTLn8pmJk-Bvu5fXz |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2xSMCFHVFWI3HgkiqLEycSF0BAgZYDAokLimwnKYWSotIKwYlP4Bv5EmbctNCeEDdLtqU4s_jNaoBdR0gnoewZW_LM4shDVujywHKEQ3GbULmaDMXaZVC54ee3_u0Y7PdrYXr9IQYON5IMo69JwMkh_UvKZbOJco4sOg6TJj5HkOjqp3mUKDwsiCAsjnJd9BWiPJ7B1iFcOZoV-RutmuvmZA7u-h_ayzJ5LHc7qqzfR3o4_vck8zBb4FB20GOcBRhL80WYqhWR9iVo0JsepuaBtTJ2Vj91mcwTGnB2-PXxSQ5_9kRpum8sQ15qveIdyF7IqUUO0CZrUOFJUd5FS9oM0X29jVidPZOzImf0iku7_rYMNyfH10cVq3iWwXrgeM9ZKgkCpRLhhcqLNMKDQIaae4n27DChuB3VumZo1kiZSjvVfqptjSgzsVPUH1J5KzCRt_J0FZij3DDUwiOrkgeZiFQWudJHBuGaO5ldgo0-eeJCtl5i6iAY2SH3oxLsDKZRKujkMk9bXVyDegtte-H6JRBDZI2fe108YuqrPTyTN-5Nf23hkdbiJdgzVBvs6NtL-HtiQ674oFo1g7W_L92G6cp1rRpXzy4v1mHGJfPd5E9uwESn3U03EeN01JZh5W93Lfk6 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV07T8MwED5BkRAL4ikKBYzEwBIpDydOxFQepUCpOoDULbKdpBSVtCpUqBs_gd_IL-HOTSPKxGbJ9mDf67vz3Rng1BHSSSh7xpY8szjykBW6PLAc4dC7TahcTY7iQztoPvG7rt9dgvN5LcysP0QZcCPJMPqaBHyUZL-EXA4GKObIocuwwpHviL1d3inVsCgCLAggLI5iXbQVojSecusCrPybFPkbrBpr09iA9QImsvqMrpuwlOZbsPpQPIRvQ5--3DAlCWyYsdvejctkntCAs4vvzy-Kx7NXyqKdsgxJPfxAE8XeKOZE8ckB61NdSFF9RUvGDMF3b4xQmo0olpAz-mRl3JvuwFPj-vGyaRW_JlgvHM2QpZIgUCoRXqi8SKP1DmSouZdozw4TelajUtQMvQ4pU2mn2k-1rREEJnaK4i2VtwuVfJine8Ac5YahFh45fTzIRKSyyJU-0o9r7mR2FWrz64sL1n-LqcFfZIfcj6pwUk4j09LJZZ4OJ7gG1Qq63sL1qyAWrj0ezZpsxNT2enEm7z-b9tfCI6XCq3BmCFTumLszeD2xoW5cb7XMYP__S49htXPViFu37fsDWHPJuTbZjTWovI8n6SEikHd1ZDjtB3x7178 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Induction+of+IgG2+and+IgG4+B-cell+memory+following+sublingual+immunotherapy+for+ryegrass+pollen+allergy&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Heeringa%2C+Jorn+J&rft.au=McKenzie%2C+Craig+I&rft.au=Varese%2C+Nirupama&rft.au=Hew%2C+Mark&rft.date=2020-05-01&rft.issn=1398-9995&rft.eissn=1398-9995&rft.volume=75&rft.issue=5&rft.spage=1121&rft_id=info:doi/10.1111%2Fall.14073&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon |